Top Biotech Companies Riding High in Belgium
Meet the most successful biotech companies in Belgium, a small country that makes a huge…
25/01/2021 - 9 minutes
Belgium
Llama-Derived Nanobodies Join the Fight Against Covid-19
Newly-launched Belgian startup ExeVir Bio will develop ‘nanobodies’ that bind very precisely to key areas…
30/07/2020 - 3 minutes
Belgian Company Harnesses Lab-on-a-Chip Technology to Diagnose Disease
The Belgian startup miDiagnostics is developing technology to diagnose diseases quickly, accurately, and at the…
01/05/2020 - 4 minutes
iTeos Therapeutics’ Cancer Immunotherapy Boosted with €114M Funding
An oversubscribed Series B2 round has seen the biopharmaceutical company iTeos Therapeutics raise €114M, which…
02/04/2020 - 3 minutes
This Startup Hits Hidden Proteins to Make Cancer Immunotherapies
With one foot in Belgium and another in the US, Orionis Biosciences combines US and…
13/03/2020 - 4 minutes
Belgian Biotech Raises €50M to Make Gene Therapy Manufacturing Cheaper
An equity investment worth up to €50M will push to market Univercells’ manufacturing technology, which…
19/02/2020 - 2 minutes
Off-The-Shelf Lung Cancer Vaccine Clinical Trial Gets €20M Boost
The French-Belgian company PDC*Line Pharma has raised a €20M Series B round to fund an…
22/01/2020 - 2 minutes
Update: Cell Therapy Biotech Raises €47M to Fund NASH Clinical Trial
Update (17/12/2019): Promethera has increased the total raised in its Series D round to €47.2M…
17/12/2019 - 2 minutes
Type 1 Diabetes Immunotherapy Shows Promise in Phase I
An immunotherapy designed by the Belgian biotech Imcyse to prevent type 1 diabetes has shown…
28/08/2019 - 3 minutes
Belgian Biotech Raises €35M to Develop Eco-Friendly Pesticides
The Belgium-based company AgroSavfe has raised a Series C round of €35M to develop an…
30/07/2019 - 2 minutes
Scientists in Belgium Cure Anthrax in Mice by Smashing Bacteria’s Armor
Belgian researchers have developed a potential treatment for anthrax that breaks down the bacteria’s thick…
17/07/2019 - 2 minutes
Belgian Biotech’s €35M Series B to Fund Potential Type 1 Diabetes Cure
The Belgian company Imcyse has raised €35M in a Series B round to develop a…
18/06/2019 - 2 minutes
